Drug target · KCNQ3

Kv7.3

Potassium voltage-gated channel subfamily Q member 3

2 compounds in the CNS pipeline act on Kv7.3.

Compounds targeting Kv7.3

CompoundActionAffinityLead programDeveloper
Azetukalner (XEN1101)Small moleculeActivator—Phase 3EpilepsyXenon Pharmaceuticals Inc.
Opakalim (BHV-7000)Small moleculeActivator—Phase 3EpilepsyBiohaven Ltd.